Jove
Visualize
Contact Us

Related Concept Videos

Brain Imaging01:14

Brain Imaging

227
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
227
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Neuralink And Brain-computer Interface-exciting Times For Artificial Intelligence.
  1. Home
  3. Neuralink And Brain-computer Interface-exciting Times For Artificial Intelligence.

Related Experiment Video

A Single-Channel and Non-Invasive Wearable Brain-Computer Interface for Industry and Healthcare
06:34

A Single-Channel and Non-Invasive Wearable Brain-Computer Interface for Industry and Healthcare

Published on: July 7, 2023

2.3K

Neuralink and Brain-Computer Interface-Exciting Times for Artificial Intelligence.

Purvish Mahendra Parikh1, Ajit Venniyoor2

  • 1Department of Clinical Hematology, Mahatma Gandhi University of Medical Sciences and Technology, Sitapur, Jaipur, Rajasthan, India.

South Asian Journal of Cancer
|May 9, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Brain-computer interfaces are revolutionizing patient care, offering new hope for those with motor paralysis and other conditions. Recent FDA approval for human trials signifies a major advancement in neurotechnology.

Keywords:
BCIhuman trialsimplantmotor paralysisoptical coherence tomography

More Related Videos

Assessment and Communication for People with Disorders of Consciousness
07:37

Assessment and Communication for People with Disorders of Consciousness

Published on: August 1, 2017

9.0K
An Experimental Platform to Study the Closed-loop Performance of Brain-machine Interfaces
10:51

An Experimental Platform to Study the Closed-loop Performance of Brain-machine Interfaces

Published on: March 10, 2011

13.7K

Related Experiment Videos

A Single-Channel and Non-Invasive Wearable Brain-Computer Interface for Industry and Healthcare
06:34

A Single-Channel and Non-Invasive Wearable Brain-Computer Interface for Industry and Healthcare

Published on: July 7, 2023

2.3K
Assessment and Communication for People with Disorders of Consciousness
07:37

Assessment and Communication for People with Disorders of Consciousness

Published on: August 1, 2017

9.0K
An Experimental Platform to Study the Closed-loop Performance of Brain-machine Interfaces
10:51

An Experimental Platform to Study the Closed-loop Performance of Brain-machine Interfaces

Published on: March 10, 2011

13.7K

Area of Science:

  • Neuroscience and biomedical engineering
  • Medical technology innovation

Background:

  • Brain-computer interfaces (BCIs) are emerging as a transformative technology.
  • Over 150,000 patients in the U.S. currently utilize brain implants.
  • Significant advancements are being made by various companies in the BCI field.

Purpose of the Study:

  • To highlight the growing significance and potential of brain-computer interfaces.
  • To underscore the impact of recent regulatory milestones, such as FDA approval for Neuralink trials.
  • To outline the potential therapeutic applications of BCIs for neurological conditions.

Main Methods:

  • Review of current advancements in brain-computer interface technology.
  • Analysis of regulatory approvals and clinical trial progress.
  • Identification of patient populations and neurological conditions that can benefit from BCIs.

    • Main Results:

    • Brain-computer interfaces are transitioning from concept to practical application.
    • FDA approval for Neuralink's human trials represents a landmark achievement.
    • BCI technology shows promise for treating motor paralysis, cerebral palsy, and involuntary movements.

    Conclusions:

    • Brain-computer interfaces are poised to significantly improve patient outcomes.
    • Continued innovation in neurotechnology will expand treatment options for neurological disorders.
    • The widespread adoption of BCIs is anticipated as the technology matures.